[Both social and economic benefits should be considered simultaneously in prevention and treatment of hereditary metabolic diseases].
Gu
Xue-fan
XF
Han
Lian-shu
LS
Ye
Jun
J
D030342:Genetic Diseases, Inborn / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D008659:Metabolic Diseases / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*